article

Issue #6 2017 – Digital Version

Posted: 14 December 2017 | | No comments yet

This issue celebrates European Pharmaceutical Review’s 21st birthday through 21 interviews with leading lights from across the pharmaceutical industry…

  • FOREWORD: Objectionable organisms in non-sterile medicinal products
    Dave Elder, David P Elder Consultancy
  • REGULATORY INSIGHT: Obstacles to success for biosimilars in the US market
    Sarfaraz K Niazi, Karyo Biologics
  • IN-DEPTH FOCUS: Raman
  • MICROBIOLOGY: A comprehensive review of the revised European Pharmacopoeia Chapter 5.1.6 (part two)
    Michael J Miller, Microbiology Consultants and rapidmicromethods.com
  • IN-DEPTH FOCUS: Formulation, Development & Delivery
  • PROCESS ANALYTICAL TECHNOLOGY: What do we need from PAT?
    Darren Whitaker and Chris Edlin, Pharmaceutical Manufacturing Technology Centre
  • IN-DEPTH FOCUS: Biopharmaceutical Development & Processing
  • PARTICLE SIZING: The importance of particle size analysis
    Dave Elder, David P Elder Consultancy; Stephen Tindal, Peter Nelson and Gene Pacowski, Catalent Pharma Solutions
  • 21st ANNIVERSARY SUPPLEMENT: 21 interviews with key opinion leaders to celebrate 21 years of European Pharmaceutical Review

The digital issue of Issue #6 2017 is restricted to logged-in members. Login or subscribe free to read it.


Send this to a friend